Clinically meaningful change threshold in health‐related quality of life among patients aged 6 months to 5 years with atopic dermatitis and their caregiver(s)/family
Abstract Background Atopic dermatitis (AD) significantly impacts health‐related quality of life (HRQoL) in children and their caregiver(s)/family. Measures to assess HRQoL include the Children's Dermatology Life Quality Index (CDLQI), Infants' Dermatitis Quality of Life Index (IDQoL) and D...
Saved in:
Main Authors: | Amy S. Paller (Author), Servando E. Marron (Author), Diane Whalley (Author), Lauren Nelson (Author), Shanshan Qin (Author), Jingdong Chao (Author), Ashish Bansal (Author), Chien‐Chia Chuang (Author), Zhixiao Wang (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Atopic Dermatitis Control Tool: Adaptation and Content Validation for Children and Caregivers of Children with Atopic Dermatitis
by: Chien-Chia Chuang, et al.
Published: (2024) -
Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis
by: Eric L. Simpson, et al.
Published: (2019) -
Dupilumab treatment reduces caregiver-reported skin pain in patients with moderate-to-severe atopic dermatitis aged 6 months to 5 years
by: Amy S. Paller, et al.
Published: (2024) -
Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey)
by: Amy S. Paller, et al.
Published: (2023) -
Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis
by: Jonathan I. Silverberg, et al.
Published: (2021)